once a week glp-1 agonist Medications: Everything You Need to Know Trends in the Development of

p38beta Mitogen- activated protein kinase signaling mediates exenatide-stimulated microglial beta-endorphin expression

Most symptoms are gastrointestinal and typically occur during the first few weeks of treatment or following a dosage increase

Why Do GLP-1 Medications Cause Side Effects

Thus, the use of combination pharmacotherapy involving other molecules in addition to gut hormones seems to be a plausible approach to treating the metabolic syndrome

Given that these results were coming from a randomised, double-blind clinical trial, the Parkinsons community got rather excited about them ( Click here to read a previous SoPD post about this particular trial)